International / International
Brazil / Brasil
Canada / Canada
Latin America / Latinoamérica
USA / USA
Albania / Albania
Austria / Österreich
Bosnia and Herzegovina / Босна и Херцеговина
Bulgaria / България
Croatia / Hrvatska
Czech Republic & Slovakia / Česká republika & Slovensko
Finland / Suomi
France / France
Germany / Deutschland
Greece / ΕΛΛΑΔΑ
Italy / Italia
Netherlands / Nederland
Nordic / Nordic
Poland / Polska
Portugal / Portugal
Romania & Moldova / România & Moldova
Slovenia / Slovenija
Serbia & Montenegro / Србија и Црна Гора
Spain / España
Sweden / Sverige
Switzerland / Schweiz
Turkey / Türkiye
UK & Ireland / UK & Ireland
India / भारत गणराज्य
Japan / 日本
Pakistan / Pākistān
Vietnam / Việt Nam
Israel / מְדִינַת יִשְׂרָאֵל
Algeria / الجزائر
Middle East / Middle East
:sharpen(level=0):output(format=jpeg)/up/dt/2022/10/Poor-periodontal-health-and-tooth-loss-linked-with-cognitive-decline-and-dementia.jpg "牙周健康状况不佳和牙齿脱落与认知能力下降和痴呆有关")
:sharpen(level=0):output(format=jpeg)/up/dt/2022/09/China-caps-cost-of-implant-therapy-1-1.jpg "中国限制种植牙治疗费用")
:sharpen(level=0):output(format=jpeg)/up/dt/2022/09/aisearc.jpg "苏格兰牙医正测试可识别龋齿的人工智能程序")
:sharpen(level=0):output(format=jpeg)/up/dt/2022/08/Artificial-intelligence-may-automate-design-of-biomimetic-single-tooth-protheses_NEW.jpg "在最近的一項實驗研究中，香港研究人員證明，他們的AI系統可以根據剩餘牙列的特徵生产磨牙义齿（紅色）的設計。 （图片：HKU）")
:sharpen(level=0):output(format=jpeg)/up/dt/2022/08/exocad_DentalCAD_3_1_Rijeka_Press-Release_1920x1080_Smile_Creator.jpg "Exocad 推出 DentalCAD 3.1 Rijeka 软件")
:sharpen(level=0):output(format=png)/up/dt/2022/02/shining-3d-logo-02.png "SHINING 3D"){kind=logo}
:sharpen(level=0):output(format=png)/up/dt/2010/11/Nobel-Biocare-Logo-2019.png "Nobel Biocare"){kind=logo}
:sharpen(level=0):output(format=png)/up/dt/2013/01/Amann-Girrbach_Logo_SZ_RGB_neg.png "Amann Girrbach"){kind=logo}
:sharpen(level=0):output(format=png)/up/dt/2014/02/A-dec.png "A-dec")
:sharpen(level=0):output(format=png)/up/dt/2014/02/3shape.png "3Shape")
:sharpen(level=0):output(format=png)/up/dt/2013/03/LM-Dental.png "LM-Dental")
:sharpen(level=0):output(format=jpeg)/up/dt/2022/08/DTCHI_0322_FINAL.jpg "DT China No. 3, 2022")
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/307114/1.jpg "DT China No. 2, 2022")
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/302868/1.jpg "DT China No. 1, 2022")
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/295582/1.jpg "DT China No. 1, 2021")
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/274907/1.jpg "DT China No. 3, 2020")
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/271655/1.jpg "DT China No. 2, 2020")
:sharpen(level=0):output(format=jpeg)/up/dt/2022/09/bannerhori1080.jpg "DenTech China 2022")
:sharpen(level=0):output(format=jpeg)/up/dt/2022/09/BANNER1920.jpg "Dental South China 2023")
E-papers
E-paper editions are exact digital copies of the DTI print publications. Readers can search and navigate through the e-paper, as well as download and print pages to read offline. In order to promote wide dissemination to our international readership, access to most e-papers is free.
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/286802/1.jpg "DT Italy No. 6, 2021")
Latest issue
DT Italy No. 6, 2021
Una corretta digitalizzazione dello studio parte da un cambiamento di visione strategica / Un progetto di aggregazione fra “neo-dentisti” e colleghi “anziani” / Resistenza agli antibiotici, grave minaccia per la salute pubblica globale / Attualità / News & Commenti / Cosmetic & Endo Tribune Italian Edition / Industry Report / Un recente studio conferma l’efficacia di CPC + CHX nella riduzione della carica virale del SARSCoV- 2 e ribadisce la ridotta attività antivirale della sola CHX / Notizie dalle Aziende / Formazione / Meeting & Congressi /
-
Una corretta digitalizzazione dello studio parte da un cambiamento di visione strategica
1 - 5 -
Un progetto di aggregazione fra “neo-dentisti” e colleghi “anziani”
1 - 6 -
Resistenza agli antibiotici, grave minaccia per la salute pubblica globale
1 - 7 -
Attualità
2 - 2 -
News & Commenti
3 - 3 -
Cosmetic & Endo Tribune Italian Edition
9 - 14 -
Industry Report
15 - 15 -
Un recente studio conferma l’efficacia di CPC + CHX nella riduzione della carica virale del SARSCoV- 2 e ribadisce la ridotta attività antivirale della sola CHX
16 - 17 -
Notizie dalle Aziende
18 - 19 -
Formazione
20 - 20 -
Meeting & Congressi
21 - 23
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/307114/1.jpg "DT China No. 2, 2022")
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/302868/1.jpg "DT China No. 1, 2022")
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/295582/1.jpg "DT China No. 1, 2021")
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/274907/1.jpg "DT China No. 3, 2020")
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/271655/1.jpg "DT China No. 2, 2020")
:sharpen(level=0):output(format=jpeg)/up/dt/2022/08/DTCHI_0322_FINAL.jpg "DT China No. 3, 2022")
